BRCA1 and breast carcinoma: “Burden of cost” (33%), “feeling no need since already diagnosed with breast cancer” (25%), “fear of discovering a genetic mutation” (23%), and “do not trust genetic test results” (16%) were reported as the main barriers among individuals who did not intend to undergo BRCA1/2 testing (Figure 1).